These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19252021)

  • 1. Risk assessment in asthma and COPD: a potential role for biomarkers?
    Taylor DR
    Thorax; 2009 Mar; 64(3):261-4. PubMed ID: 19252021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility of biomarkers in asthma and COPD.
    Snell N; Newbold P
    Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in the assessment and management of airways diseases.
    Taylor DR; Pavord ID
    Postgrad Med J; 2008 Dec; 84(998):628-34; quiz 633. PubMed ID: 19201936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4.
    Gogate S; Katial R
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):154-7. PubMed ID: 18317025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath condensate and airway inflammation.
    Hoffmeyer F; Raulf-Heimsoth M; Brüning T
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):16-22. PubMed ID: 19532089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives.
    Ambrosino N; Paggiaro P
    Expert Rev Respir Med; 2012 Feb; 6(1):117-27. PubMed ID: 22283584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Redington AE
    Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.
    Verrills NM; Irwin JA; He XY; Wood LG; Powell H; Simpson JL; McDonald VM; Sim A; Gibson PG
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1633-43. PubMed ID: 21471098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
    Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
    Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.
    Kharitonov SA
    Vascul Pharmacol; 2005 Dec; 43(6):371-8. PubMed ID: 16198155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endogenous nitric oxide in obstructive pulmonary diseases].
    Toczyska I; Chciałowski A; Lubiński W
    Wiad Lek; 2005; 58(3-4):238-42. PubMed ID: 16119172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional assessment of older people with asthma and COPD: clinical management and health status.
    McDonald VM; Simpson JL; Higgins I; Gibson PG
    Age Ageing; 2011 Jan; 40(1):42-9. PubMed ID: 21087988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating COPD from asthma in clinical practice.
    Mosenifar Z
    Postgrad Med; 2009 May; 121(3):105-12. PubMed ID: 19491547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in asthma.
    Murugan A; Prys-Picard C; Calhoun WJ
    Curr Opin Pulm Med; 2009 Jan; 15(1):12-8. PubMed ID: 19077700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.